Pengli Wang

779 total citations
23 papers, 646 citations indexed

About

Pengli Wang is a scholar working on Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Pengli Wang has authored 23 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Cancer Research and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Pengli Wang's work include MicroRNA in disease regulation (7 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (4 papers). Pengli Wang is often cited by papers focused on MicroRNA in disease regulation (7 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (4 papers). Pengli Wang collaborates with scholars based in China, United States and Australia. Pengli Wang's co-authors include Yang Xia, Bin Liu, Yijiang Chen, Zhicheng He, Yijiang Chen, Miaomiao Jiang, Lan Yang, Chun Guang Li, Xian Zhou and Ling Fu and has published in prestigious journals such as Scientific Reports, FEBS Letters and Molecules.

In The Last Decade

Pengli Wang

21 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pengli Wang China 13 432 273 75 74 47 23 646
Fangliang Zhou China 11 391 0.9× 182 0.7× 67 0.9× 60 0.8× 35 0.7× 19 627
Cong Zhang China 19 625 1.4× 315 1.2× 82 1.1× 67 0.9× 52 1.1× 45 950
Cong Wei China 19 381 0.9× 198 0.7× 38 0.5× 73 1.0× 26 0.6× 47 784
Ebru Alp Türkiye 16 276 0.6× 169 0.6× 95 1.3× 60 0.8× 58 1.2× 35 626
Seung‐Nam Jung South Korea 15 426 1.0× 195 0.7× 129 1.7× 60 0.8× 36 0.8× 29 790
Yifeng Lin China 8 611 1.4× 243 0.9× 34 0.5× 55 0.7× 47 1.0× 17 944
Zhiping Miao China 13 482 1.1× 209 0.8× 69 0.9× 42 0.6× 45 1.0× 28 726
Yijun Xu China 15 597 1.4× 384 1.4× 94 1.3× 75 1.0× 37 0.8× 39 895
Shikun Yang China 16 444 1.0× 187 0.7× 127 1.7× 53 0.7× 43 0.9× 35 773

Countries citing papers authored by Pengli Wang

Since Specialization
Citations

This map shows the geographic impact of Pengli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengli Wang more than expected).

Fields of papers citing papers by Pengli Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengli Wang. The network helps show where Pengli Wang may publish in the future.

Co-authorship network of co-authors of Pengli Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Pengli Wang. A scholar is included among the top collaborators of Pengli Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengli Wang. Pengli Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xuan, Pengli Wang, Rong Jiang, et al.. (2025). Research advances in protein prenylation in cardiovascular diseases. European Journal of Pharmacology. 1005. 178093–178093.
2.
Yang, Ziyu, Tao Sun, Pengli Wang, et al.. (2024). The functional subclasses of AT1 receptor autoantibody in patients with coronary heart disease. Biochemical Pharmacology. 229. 116546–116546.
3.
Yang, Shuanying, et al.. (2024). The lncRNA GUSB Pseudogene 11 (GUSBP11) Promotes the Tumor Growth and Metastasis in Lung Adenocarcinoma.. PubMed. 30(5). 256–263. 1 indexed citations
4.
Liu, Tian, et al.. (2023). Hawthorn leaves flavonoids attenuate cardiac remodeling induced by simulated microgravity. Pharmaceutical Biology. 61(1). 683–695. 1 indexed citations
5.
Jiang, He, Ying Xiao, Pengli Wang, et al.. (2022). Resveratrol inhibits the expression of RYR2 and is a potential treatment for pancreatic cancer. Naunyn-Schmiedeberg s Archives of Pharmacology. 395(3). 315–324. 11 indexed citations
6.
Zhang, Jun, Jieyi Li, Liu Z, et al.. (2022). Leukocyte CH25H is a potential diagnostic and prognostic marker for lung adenocarcinoma. Scientific Reports. 12(1). 22201–22201. 8 indexed citations
7.
Wang, Pengli, et al.. (2022). Analysis of intention and influencing factors on mobile information follow-up service in HIV/AIDS in a city in China. Frontiers in Public Health. 10. 997681–997681. 3 indexed citations
8.
Zhou, Xian, Ling Fu, Pengli Wang, et al.. (2021). Drug-herb interactions between Scutellaria baicalensis and pharmaceutical drugs: Insights from experimental studies, mechanistic actions to clinical applications. Biomedicine & Pharmacotherapy. 138. 111445–111445. 48 indexed citations
9.
Wang, Pengli, et al.. (2021). Thioredoxin‐interacting protein is a favored target of miR‐125b, promoting metastasis and progression of pancreatic cancer via the HIF1α pathway. Journal of Biochemical and Molecular Toxicology. 35(7). e22782–e22782. 10 indexed citations
10.
Wang, Pengli, et al.. (2021). miR-125b enhances metastasis and progression of cancer via the TXNIP and HIF1α pathway in pancreatic cancer. Cancer Biomarkers. 31(1). 27–38. 5 indexed citations
11.
Wang, Pengli, et al.. (2020). Triterpenoids From Alisma Species: Phytochemistry, Structure Modification, and Bioactivities. Frontiers in Chemistry. 8. 363–363. 22 indexed citations
12.
Wang, Pengli, Chenyang Li, Jia Li, et al.. (2020). Salidroside simultaneously reduces de novo lipogenesis and cholesterol biosynthesis to attenuate atherosclerosis in mice. Biomedicine & Pharmacotherapy. 134. 111137–111137. 37 indexed citations
13.
Zhou, Xiaohe, Tao Li, Yufei Chen, et al.. (2019). Mesenchymal stem cell‑derived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway. International Journal of Oncology. 54(5). 1843–1852. 82 indexed citations
14.
Wang, Pengli, et al.. (2018). The Association Between AURKA Gene rs2273535 Polymorphism and Gastric Cancer Risk in a Chinese Population. Frontiers in Physiology. 9. 1124–1124. 15 indexed citations
15.
Xia, Yang, Zhicheng He, Bin Liu, Pengli Wang, & Yijiang Chen. (2015). Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway. Molecular Medicine Reports. 12(3). 4530–4537. 108 indexed citations
16.
Shu, Rong, Wendy Wong, Quanhong Ma, et al.. (2015). APP intracellular domain acts as a transcriptional regulator of miR-663 suppressing neuronal differentiation. Cell Death and Disease. 6(2). e1651–e1651. 70 indexed citations
17.
Xia, Yang, et al.. (2014). Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer. Molecular Medicine Reports. 10(5). 2575–2579. 50 indexed citations
18.
Xia, Yang, et al.. (2014). Downregulation of miR‐638 promotes invasion and proliferation by regulating SOX2 and induces EMT in NSCLC. FEBS Letters. 588(14). 2238–2245. 66 indexed citations
19.
Wang, Pengli, L Ma, Haiyan Wang, et al.. (2005). Association between Polymorphisms of Vitamin D Receptor Gene ApaI, BsmI and TaqI and Muscular Strength in Young Chinese Women. International Journal of Sports Medicine. 27(3). 182–186. 37 indexed citations
20.
Hu, Yifei, K. R. Purushotham, Pengli Wang, Ralph Dawson, & Michael G. Humphreys‐Beher. (1994). Downregulation of beta-adrenergic receptors and signal transduction response in salivary glands of NOD mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 266(3). G433–G443. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fangliang Zhou Breakdown of academic impact, for papers by Cong Zhang Breakdown of academic impact, for papers by Cong Wei Breakdown of academic impact, for papers by Ebru Alp Breakdown of academic impact, for papers by Seung‐Nam Jung Breakdown of academic impact, for papers by Yifeng Lin Breakdown of academic impact, for papers by Zhiping Miao Breakdown of academic impact, for papers by Yijun Xu Breakdown of academic impact, for papers by Shikun Yang
Rankless by CCL
2026